EndoSurofICH: Comparison Between Stereotactic Aspiration and Intra-endoscopic Surgery to Treat Intracerebral Hemorrhage

Sponsor
Nanfang Hospital of Southern Medical University (Other)
Overall Status
Unknown status
CT.gov ID
NCT02515903
Collaborator
Shenzhen People's Hospital (Other)
100
1
2
18.1
5.5

Study Details

Study Description

Brief Summary

Views for surgery method selection of intracerebral hemorrhage are still controversial. Since the application of neuroendoscopic technique in intraventricular hemorrhage was confirmed effective and safe, some investigators have attempted to use endoscopic strategies to evacuate intracerebral hematomas. Some significant advances have also been reported in endoscopic hematoma evacuation when compared to conventional craniotomy. However, it is still crucial to implement a prospective and controlled study to evaluate the efficiency and safety of endoscopic technique in the treatment of intracerebral hemorrhage. In this study, the investigators will exclusively select some patients with intracerebral hemorrhage in the basal ganglia region. This study will compare the efficacy and safety of endoscopic surgery versus stereotactic aspiration on neurologic outcomes for patients with intracerebral hemorrhage.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Intra-endoscopic surgery
  • Procedure: Placebo:stereotactic aspiration surgery
N/A

Detailed Description

Although the incidence and mortality of spontaneous intracerebral hemorrhage (ICH) have been decreased with the improved management of high blood pressure, ICH may induce serious disability for the patients and continue to be a major socioeconomic problem. The evacuation of ICH using open craniotomy or computer tomography (CT)-guided stereotaxy may improve the survival rate of these patients but failed to prove efficacy in improving patients' functional outcome despite numerous efforts. Endoscopy-guided evacuation of ICH provides a less invasive and quicker surgical decompression, which may potentially improve the functional outcome for patients. In previous studies, endoscope-guided evacuation of ICH is often referred to as that an endoscope only provides an illuminating system while the operating channel is independent from the endoscope (endoscopy-controlled microneurosurgery or endoscopy-assisted microneurosurgery). In recent years, authors have been committed to explore the procedure of intra-endoscopy-guided evacuation of ICH, which means that the illuminating channel, the irrigation-aspiration channel and the working channel are all located in the endoscope. This kind of procedure can be called as real endoscopic neurosurgery (EN), which may potentially decrease the operative concomitant injuries at the most extent. However, the inherent drawbacks of intra-endoscopic procedures, including the limited visualization of the surgical field and the difficult maintenance of patency of the aspiration wand, can offset the advantages in some instances. The authors exclusively invented a special endoscopic transparent sheath for guiding hematoma puncture and an agitation-aspiration system (AAS) for keeping patency of the aspiration wand. Detailed procedures of their application will be implemented and verified in a series of patients with intracerebral hemorrhage. Meanwhile, the mortality rate, complications and other outcome parameters between this procedure and CT-guided procedures will be compared.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Comparison Between Stereotactic Aspiration and Intra-endoscopic Surgery to Treat Intracerebral Hemorrhage
Study Start Date :
May 1, 2015
Anticipated Primary Completion Date :
May 1, 2016
Anticipated Study Completion Date :
Nov 1, 2016

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intra-endoscopy

This intervention arm will receive intra-endoscopic evacuation surgery for ICH.

Procedure: Intra-endoscopic surgery
Intra-endoscopic surgery for evacuation of ICH

Placebo Comparator: Stereotactic Aspiration

This arm will receive stereotactic aspiration surgery for ICH evacuation.

Procedure: Placebo:stereotactic aspiration surgery
Placebo:stereotactic aspiration surgery for evacuation of ICH

Outcome Measures

Primary Outcome Measures

  1. Mortality rate [90-day]

    all-cause motality rate within 90 days after the surgery

Secondary Outcome Measures

  1. operative time [24 h]

    the period from skin incision to wound suture

  2. days of ICU stay [14 day]

    the period between the end of the surgery to leaving the ICU

  3. remnant blood in the hematoma after surgery [12 hour]

    this parameter will be monitored by CT scan immediately after the surgery

  4. Glasgow coma score [28 day]

    the GCS will be evaluated by a senior doctor 28 days after the surgery

  5. Glasgow outcome score [90-day]

    the GCS will be evaluated by a senior doctor 28 days after the surgery

  6. In-hospital cost [28 day]

    all medical cost during the in-hospital period

  7. rehemorrhage rate [3 day]

    Rehemorrhage almost occurs within 3 days after the surger. So cranial CT scan will be performed routinely 3 days later after surgery to evaluate the rehemorrhage rate

  8. intracranial infection [14 day]

    If the patient underwent a period of fever, cerebral fluid will be withdrawn by means of lumbar puncture and tested to verify whether the intracranial infection occurs

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • primary basal ganglion region intracerebral hemorrhage

  • older than 18 years

  • admitted within 6 h after onset of ICH

Exclusion Criteria:
  • other type of ICH than acute primary intracerebral hemorrhage

  • patients who need neurosurgery

  • life expectancy less than 3 months due to comorbid disorders

  • confirmed malignant disease (cancer)

  • confirmed acute myocardial infarction

  • hepatitis and/liver cirrhosis

  • renal failure

  • infectious disease (HIV, endocarditis etc.)

  • current or previous hematologic disease

  • women of childbearing age if pregnant

  • participation in another study within the preceding 30 days

Contacts and Locations

Locations

Site City State Country Postal Code
1 Nanfang Hospital of Southern University Guangzhou Guangdong China 518000

Sponsors and Collaborators

  • Nanfang Hospital of Southern Medical University
  • Shenzhen People's Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Nanfang Hospital of Southern Medical University
ClinicalTrials.gov Identifier:
NCT02515903
Other Study ID Numbers:
  • NFYY-NSD-001
First Posted:
Aug 5, 2015
Last Update Posted:
Aug 5, 2015
Last Verified:
Aug 1, 2015

Study Results

No Results Posted as of Aug 5, 2015